中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:(Anni WU)

1.Clinical Efficacy Comparison among Dezocine, Fentanyl and Sufentanil in Fibrobronchoscope-guided Con-scious Endotracheal Intubation

Anni XU ; Xiaoyang WU

China Pharmacist 2017;20(9):1604-1607

2.Effects of magnanimous therapy on the magnanimous and enterprising traits of lung cancer patients and related factors

Qihui MA ; Qingxing CHEN ; Anni YAN ; Qianyu LIU ; Lanlan WU ; Yueying WANG ; Xuewei HUANG

Chinese Journal of Behavioral Medicine and Brain Science 2020;29(1):27-32

3.A family of primary familial brain calcification caused by myogenesis regulating glycosidase gene mutation

Ying LIU ; Yiheng ZENG ; Xiangping YAO ; Anni ZHANG ; Xuling WU ; Dian HE

Chinese Journal of Neurology 2021;54(9):935-942

4.Effects of Tai Chi on health outcomes in patients with type 2 diabetes mellitus:A systematic review and meta-analysis

Cai YIQING ; Liu XIN ; Zhao ANNI ; Mao JUNRU ; Guo XIANGYU ; Li GUANGZONG ; Yang JING ; Wu YINGQI ; Fei YUTONG

Journal of Traditional Chinese Medical Sciences 2022;9(2):108-120

5.Solitary cervical submental metastasis of papillary thyroid carcinoma:one case report

Yanhua TONG ; Yingzhen CHEN ; Qiongmei WANG ; Caijiao WANG ; Qing ZHU ; Anni WU ; Yu LU ; Jiejie YAO

Journal of Surgery Concepts & Practice 2024;29(2):179-181

6.Anti-bacterial effect and its mechanism of lavender essential oil against multi-drug resistant Acinetobacter baumannii

Man ZHAO ; Zijing WU ; Cun SUN ; Yan YE ; Ting CHEN ; Shulin LIU ; Baohang ZHU ; Anni ZHAO ; Zhen SONG ; Yun YANG ; Hongwu SUN ; Hao ZENG

Journal of Army Medical University 2024;46(18):2046-2056

7.Heliangin acts as a covalent ligand of RPS2 that disrupts pre-rRNA metabolic processes in NPM1-mutated acute myeloid leukemia.

Yin FENG ; Yefan HAN ; Anni HU ; Yi QU ; Yili HU ; Hao WU ; Xinzhi WANG ; Li HE

Acta Pharmaceutica Sinica B 2023;13(2):598-617

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO